tirzepatide from eli lilly Lilly's scores again, this time in 2 sleep apnea trials Eli Lilly, Maker of Mounjaro

Within the SGLT2i cohort, 47% received empagliflozin, 27% received dapagliflozin and 25% received canagliflozin

For others, particularly those with a history of disordered eating, a GLP-1 appetite suppressant effect can complicate recovery by reinforcing restrictive patterns or making it harder to follow a meal plan

Kankaanranta H, Kauppi P, Tuomist LE, Ilmarinen P

Semaglutide helps people lose weight overall, but its effects on belly fat are only one aspect of the total body fat decrease

Phentermine is a stimulant that suppresses appetite but is typically only recommended for short-term use due to the potential for side effects and dependence